20 articles
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
Age-tailored cognitive behavioral intervention tested in 20 older women with binge eating disorder in pilot study.
A Phase 1 trial examines whether Botulinum toxin in the glabella and forehead lifts mood and self-appearance satisfaction in returning Botox patients.
A completed pilot trial tests adapted Dialectical Behavior Therapy to reduce suicidality in aging family caregivers of AD/ADRD patients.
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
Study reveals how air quality during exercise affects cognitive performance, testing different workout intensities with and without air purification.
A completed RCT tests whether treating insomnia with CBT-I can improve cognition and slow amyloid buildup in adults aged 60–85.
A completed Canadian platform trial enrolls 354 at-risk adults in a multidomain online brain health program targeting dementia prevention.
12-week study reveals how aerobic and strength training improve cognitive performance by altering stress hormones and brain proteins.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
University of Miami researchers tested whether fast-paced resistance training could improve both cardiovascular fitness and cognitive function.
Combining Mediterranean-DASH diet with nature therapy targets hypertension and cognitive decline in older adults.
A VA-sponsored trial tested whether the blood pressure drug prazosin could remove toxic proteins linked to CTE and Alzheimer's in combat veterans.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
Small study reveals BDNF genetic variant could influence exercise's cognitive and cardiovascular benefits in healthy men.
A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
